{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T06:36:53Z","timestamp":1772951813723,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer New York","isbn-type":[{"value":"9781441913982","type":"print"},{"value":"9781441913999","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-4419-1399-9_2","type":"book-chapter","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T13:14:47Z","timestamp":1265634887000},"page":"15-19","source":"Crossref","is-referenced-by-count":30,"title":["Regulation of Angiogenesis by Macrophages"],"prefix":"10.1007","author":[{"given":"Rajendra S.","family":"Apte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,28]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm950","volume":"9","author":"J Ambati","year":"2003","unstructured":"Ambati J, Anand A, Fernandez S et al (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9:1390\u20131397","journal-title":"Nat Med"},{"key":"2_CR2","first-page":"1277","volume":"38","author":"RS Apte","year":"1997","unstructured":"Apte RS, Mayhew E, Niederkorn JY (1997) Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest Ophthalmol Vis Sci 38:1277\u20131282","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.4049\/jimmunol.156.8.2667","volume":"156","author":"RS Apte","year":"1996","unstructured":"Apte RS, Niederkorn JY (1996) Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol 156:2667\u20132673","journal-title":"J Immunol"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1371\/journal.pmed.0030310","volume":"3","author":"RS Apte","year":"2006","unstructured":"Apte RS, Richter J, Herndon J et al (2006) Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3:310\u2013320","journal-title":"PLoS Med"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432\u20131444","journal-title":"N Engl J Med"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"e3381","DOI":"10.1371\/journal.pone.0003381","volume":"3","author":"DS Dace","year":"2008","unstructured":"Dace DS, Khan AA, Kelly J et al (2008) Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS ONE 3:e3381","journal-title":"PLoS ONE"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1126\/science.1110189","volume":"308","author":"AO Edwards","year":"2005","unstructured":"Edwards AO, Ritter R 3rd, Abel KJ et al (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421\u2013424","journal-title":"Science"},{"key":"2_CR8","first-page":"1567","volume":"43","author":"DG Espinosa-Heidmann","year":"2002","unstructured":"Espinosa-Heidmann DG, Suner I, Hernandez EP et al (2002) Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 43:1567\u20131573","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1167\/iovs.03-0038","volume":"44","author":"DG Espinosa-Heidmann","year":"2003","unstructured":"Espinosa-Heidmann DG, Suner IJ, Hernandez EP et al (2003) Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3586\u20133592","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685\u20131695","journal-title":"N Engl J Med"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/6509","volume":"5","author":"HJ Kaplan","year":"1999","unstructured":"Kaplan HJ, Leibole MA, Tezel T et al (1999) Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med 5:292\u2013297","journal-title":"Nat Med"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1172\/JCI32430","volume":"117","author":"J Kelly","year":"2007","unstructured":"Kelly J, Khan AA, Yin J et al (2007) Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest 117:3421\u20133426","journal-title":"J Clin Invest"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ajo.2003.11.069","volume":"137","author":"R Klein","year":"2004","unstructured":"Klein R, Peto T, Bird A et al (2004) The epidemiology of age-related macular degeneration. Am J Ophthalmol 137:486\u2013495","journal-title":"Am J Ophthalmol"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1084\/jem.20042307","volume":"201","author":"HH Lin","year":"2005","unstructured":"Lin HH, Faunce DE, Stacey M et al (2005) The macrophage F4\/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med 201:1615\u20131625","journal-title":"J Exp Med"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature03928","volume":"437","author":"IB Lobov","year":"2005","unstructured":"Lobov IB, Rao S, Carroll TJ et al (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437:417\u2013421","journal-title":"Nature"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0602325","volume":"73","author":"DM Mosser","year":"2003","unstructured":"Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73:209\u2013212","journal-title":"J Leukoc Biol"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1172\/JCI23298","volume":"115","author":"S Nakao","year":"2005","unstructured":"Nakao S, Kuwano T, Tsutsumi-Miyahara C et al (2005) Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1beta-induced neovascularization and tumor growth. J Clin Invest 115:2979\u20132991","journal-title":"J Clin Invest"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ni1328","volume":"7","author":"JY Niederkorn","year":"2006","unstructured":"Niederkorn JY (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7:354\u2013359","journal-title":"Nat Immunol"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431","journal-title":"N Engl J Med"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1167\/iovs.03-0097","volume":"44","author":"E Sakurai","year":"2003","unstructured":"Sakurai E, Anand A, Ambati BK et al (2003) Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3578\u20133585","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.2741\/3066","volume":"13","author":"G Sethi","year":"2008","unstructured":"Sethi G, Sung B, Aggarwal BB (2008) TNF: a master switch for inflammation to cancer. Front Biosci 13:5094\u20135107","journal-title":"Front Biosci"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1146\/annurev.immunol.23.021704.115816","volume":"23","author":"PR Taylor","year":"2005","unstructured":"Taylor PR, Martinez-Pomares L, Stacey M et al (2005) Macrophage receptors and immune recognition. Annu Rev Immunol 23:901\u2013944","journal-title":"Annu Rev Immunol"},{"key":"2_CR23","first-page":"3209","volume":"40","author":"U Welge-Lussen","year":"1999","unstructured":"Welge-Lussen U, Wilsch C, Neuhardt T et al (1999) Loss of anterior chamber-associated immune deviation (ACAID) in aged retinal degeneration (rd) mice. Invest Ophthalmol Vis Sci 40:3209\u20133214","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1023\/A:1025643303914","volume":"18","author":"R Leeuwen van","year":"2003","unstructured":"van Leeuwen R, Klaver CC, Vingerling JR et al (2003) Epidemiology of age-related maculopathy: a review. Eur J Epidemiol 18:845\u2013854","journal-title":"Eur J Epidemiol"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-1399-9_2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:21:45Z","timestamp":1685406105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-1399-9_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,28]]},"ISBN":["9781441913982","9781441913999"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-1399-9_2","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12,28]]}}}